Kiran Mazumdar-Shaw joins USP Board of Trustees

Ms Shaw will help to guide USP's policies, finances and strategic direction as a member of the Board. In addition to her role on USP's Board of Trustees, Ms Shaw will serve as a member of the USP Biologics Advisory Group

kiran-mazumdar-365

Ms Kiran Mazumdar-Shaw, Chairman and Managing Director and founder of Biocon India joined the Board of Trustees to the U.S. Pharmacopeial Convention (USP), a scientific, nonprofit, standards-setting organization that advances public health through public standards and related programs that help ensure the quality, safety, and benefit of medicines and foods.

A biotechnology entrepreneur and executive with global standing, Ms Shaw will help to guide USP's policies, finances and strategic direction as a member of the Board. In addition to her role on USP's Board of Trustees, Ms Shaw will serve as a member of the USP Biologics Advisory Group. Headquartered in the United States, USP operates facilities with laboratory and customer support operations in Brazil, India and China, with a sales office in Switzerland.

"As a businesswoman, public health advocate and philanthropist, Ms Kiran Mazumdar-Shaw has innovated and campaigned tirelessly for affordable medications on behalf of patients in India and worldwide for decades," said Dr. Roger L. Williams, Chief Executive Officer of USP. "We are honored to have her serve on USP's Board of Trustees, where her leadership and expertise will be utilized to help guide the organization as it advances its mission to improve the health of people around the world through public standards and related programs that help ensure the quality, safety, and benefit of medicines and foods."

Ms Shaw is the second non-U.S. member of the USP Board of Trustees. The first was Dr. Judith Oulton, who served on the USP Board of Trustees in the 2005-2010 cycle. Ms Shaw is honored in this cycle as being an appointed member of the Board, which is allowed for three distinguished members of the professional community by virtue of changes to USP's By-laws that occurred at the 2010 Convention. The decision to seek Shaw was made by the USP Board's Governance Committee, chaired by Dr. Marilyn Speedie, and endorsed unanimously by the USP Board.

Under her stewardship Biocon has evolved into India's largest biotech company committed to innovation and affordability to deliver world class therapeutics to the patients across the globe. A pioneer of the biotechnology industry in India, Ms Shaw, has made her country proud with a globally recognized bio-pharma enterprise-Biocon.

Leave a Reply Sign in

Notify me of follow-up comments via e-mail address

Post Comment

Survey Box

GST

GST: Boon or Bane for Healthcare?

Send this article by email

X